Skip to main content
Main analysis: Avgol 2025: volume is back, but profit still waits for the U.S. line
February 25, 2026~7 min read

Avgol: Receivables Came Down, but How Much of the Improvement Is Real Cash Quality

Avgol's year-end receivables balance looked cleaner in 2025, but part of that improvement came from non-recourse discounting and reverse factoring, not just better collections. At the same time, 56.6% of revenue still sat with two customers under structures that do not create a hard volume floor.

What This Follow-Up Is Isolating

The main article already framed the gap between returning volume and profit that still needs the US line to fully come through. This follow-up isolates a narrower question: did the lower year-end receivables balance really mean better cash quality, or did part of the cleanup simply come from moving receivables to financial institutions.

The short answer: there was some operational improvement, but the balance sheet looks cleaner than pure organic cash conversion would suggest. Q4 average customer days, excluding discounting, improved to 57 days from 61 a year earlier. That is a real positive. But in the same year the company increased ordinary non-recourse receivables discounting to $32.6 million from $26.1 million, and also increased reverse factoring tied to major customers to $26.1 million from $24.0 million.

That distinction matters because this is where credit quality and cash quality split apart. Avgol's major customers carry high credit quality and the related allowance is negligible. The risk is not that the largest customers will fail to pay. The risk is different: the balance sheet can look better on collections even when part of the improvement is actually coming from selling receivables early, while more than half of revenue still sits with two customers that do not provide a hard binding volume floor.

Receivables Fell, But the Financing Channel Expanded

Net receivables fell to $28.0 million from $34.0 million. On the surface that looks like a clean working-capital improvement for an industrial business. But in its own explanation of the balance-sheet change, the company says the roughly $6.0 million decline came mainly from higher receivables discounting. In other words, this was not just about customers paying faster. It was also about receivables leaving the balance sheet.

The economic point is not that the cash is somehow unreal. The cash does come in. The issue is interpretive. Once the transactions are treated as true sales without recourse, receivables are derecognized from the balance sheet, and the difference between book value and proceeds is recognized in finance expense. That means a lower receivables balance is no longer a clean standalone measure of collection quality. It becomes a blended outcome of collections, credit terms, and financing.

Item20242025How to read it
Net receivables on balance sheet$34.0 million$28.0 millionA cleaner accounting balance, but not necessarily a fully organic improvement
Non-recourse receivables discounting$26.1 million$32.6 millionMore receivables moved off balance sheet through financing
Reverse factoring tied to major customers$24.0 million$26.1 millionThat channel expanded too
Q4 average customer days, excluding discounting6157This is the genuine operating signal
Finance expense from receivables discounting$3.9 million$4.6 millionThe working-capital relief came with a cost
On-balance-sheet receivables versus discounting channels

This is the key point because it breaks the easy reading of the line item. If you look only at the balance sheet, you could conclude that Avgol closed 2025 with customers paying materially better. Once discounting and its financing cost are brought back into the picture, the read changes: part of the improvement was operational, but part of it was purchased.

There Was a Real Cash Signal, But Only a Partial One

The consolidated cash-flow statement still shows that not everything was cosmetic. The customer line contributed $9.2 million to operating cash flow, and inventory contributed another $4.0 million. On the other hand, suppliers and service providers used $5.4 million, and other payables used another $2.3 million. Altogether, the working-capital contribution was only $2.7 million.

Working-capital contribution to 2025 operating cash flow

So there was some genuine in-year improvement. But that signal does not justify an overly optimistic reading of the closing receivables balance by itself. Operating cash flow fell to $35.0 million from $42.5 million in 2024, and cash and cash equivalents fell to $51.2 million from $60.9 million. Looking at the full cash picture, 2025 does not read like a year in which cash quality simply stepped up across the board.

The broader working-capital picture points the same way. Despite the lower receivables balance, the consolidated working-capital deficit widened to $21.4 million from $9.5 million. The company says it is still improving collections, reducing inventory, and negotiating better supplier terms, but the overall balance-sheet picture did not come out of the year with a more comfortable working-capital cushion. Anyone treating the receivables decline as proof of a broad cash-quality improvement is reading too much into one line.

There is also a visible price tag. Finance expense from receivables discounting rose to $4.6 million from $3.9 million. Part of the cash flexibility is therefore coming through a financing mechanism that carries a real cost, not through a free improvement in underlying working-capital quality. That does not make it wrong. It does change the quality of the improvement.

More Than Half of Revenue Still Sits With Two Customers, Without a Volume Floor

The second leg of the thesis is customer concentration. In 2025, P&G accounted for 31.1% of sales and KC for 25.5%. Together they represented 56.6% of revenue. The combined share was 54.0% in 2024 and 54.4% in 2023. In other words, concentration did not ease. If anything, it tightened slightly.

Revenue concentration in the two largest customers

The problem is not only the percentage. It is also the structure of the agreements. Both customers sit under relatively long framework arrangements, with P&G through December 31, 2026 and KC through April 30, 2026. That sounds comforting at first glance, but the framework agreements are not orders and do not contain binding quantity commitments. In P&G's case there are also regional agreements that spell out purchase forecasts, pricing, and product types, while KC's relationship rests on the Award Letter and the extended framework agreement. In both cases, actual sales are executed through Purchase Orders in the ordinary course.

That matters because it defines exactly what factoring does and does not solve. Factoring and reverse factoring can improve the timing of cash once receivables already exist. They do not answer whether the same volume will still show up tomorrow morning. Actual volumes remain exposed to raw-material prices, competitor pricing, market trends, and changes in the customer's own product and production mix.

There is one nuance that should not be overstated. In certain cases where raw-material pricing is fixed in advance for a year, the structure can include a take-or-pay commitment on the full raw-material quantity specified in the contract. But that is not the standard structure of the major-customer frameworks, and it certainly does not turn most of the revenue base into fully committed volume.

This is where the credit point and the concentration point merge. Expected credit losses on highly rated major customers are just 0.02%, and the year-end allowance tied to those customers is only about $2 thousand. So the issue is not weak counterparties. Quite the opposite. The issue is that more than half of revenue sits with very strong customers, which makes their influence over terms, order cadence, and financing structure more important than the narrow question of whether they will pay.

Bottom Line

The decline in receivables in 2025 was not an illusion, but it was not clean proof of better cash quality either. Part of it came from some improvement in customer days and in-year working-capital release. A meaningful part of it also came from expanding non-recourse receivables discounting, which moved balances off the balance sheet and moved the cost into finance expense.

Put that next to a 56.6% revenue concentration in P&G and KC, under frameworks that do not bind volume, and the picture becomes much sharper: Avgol is not dealing with weak customers. It is dealing with the gap between high customer credit quality and cash quality that is not fully generated organically. A quick read of the balance sheet can miss that distinction.

The next filings need to prove two things at the same time. First, customer days need to stay under control without another step-up in receivables discounting. Second, volumes from the two anchor customers need to keep showing up as actual orders, not just as forecasts and framework language. Without those two proofs, the lower receivables balance will remain more of a cleaner accounting picture than a clearly higher-quality cash outcome.

Editorial note
Found an issue in this analysis?
Editorial corrections and sharp feedback help keep the coverage honest.
Report a correction